Indian drug makers are finding themselves under the gun as run-ins with global drug regulators are on the rise. This is being seen as a golden opportunity by Merck Millipore, the life sciences division of German drug maker Merck, which also works on setting up high quality drug manufacturing processes, reports Archana Shukla.
first published: Jan 8, 2015 09:51 pm
A collection of the most-viewed Moneycontrol videos.
Live: Is Nifty likely to stay in profit-booking mode? | Opening Bell
Groww CEO Lalit Keshre on ₹62,000 Crore IPO, Sebi regulations, valuation expectation and more
How Income Plus Arbitrage Fund of Fund Can Help You Get Stable, Tax-Efficient Returns
Nifty fails to hold 26,000, slips below 25,900 | Closing Bell
